The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail


Pfizer Europe MA EEIGEU/1/02/209/001

Main Information

Trade NameDynastat
Active SubstancesParecoxib Sodium
Dosage FormPowder for solution for injection
Licence HolderPfizer Europe MA EEIG
Licence NumberEU/1/02/209/001

Group Information

ATC CodeM01AH Coxibs
M01AH04 parecoxib


License statusAuthorised
Licence Issued22/03/2002
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back